Skip to main content

Series B Pharmaceutical Companies

Explore 58 pharmaceutical startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
58
Total Funding
$1.4B
Avg Funding
$54.9M
Cities
20

Export 58 Series B Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
London, United Kingdom
$60.0M
raised

Basecamp Research leverages their unprecedented knowledge of the natural world to create better medicines, better food and better products

Oct 2024
Series B

Founder Contacts

19,000+ verified contacts

San Diego, United States
$50.0M
raised

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

Sep 2024
Series B

Founder Contacts

19,000+ verified contacts

Ohio, United States
$12.3M
raised

Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.

Aug 2024
Series B

Founder Contacts

19,000+ verified contacts

Seattle, United States
$144.0M
raised

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Aug 2024
Series B

Founder Contacts

19,000+ verified contacts

Denver, United States
$33.0M
raised

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

Jul 2024
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 58 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Tel Aviv, Israel
$80.0M
raised

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

Jul 2024
Series B

Founder Contacts

19,000+ verified contacts

$10.0M
raised

A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint

Jul 2024
Series B

Founder Contacts

19,000+ verified contacts

Genive, Switzerland
$85.7M
raised

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

Jun 2024
Series B

Founder Contacts

19,000+ verified contacts

Cincinnati, United States
$73.0M
raised

CinRx Pharma develops therapies for unmet needs, leveraging partnerships and expertise to advance new molecular entities.

May 2024
Series B

Founder Contacts

19,000+ verified contacts

Fishers, United States
$42.9M
raised

INCOG BioPharma services include injectable drug product formulation, analytical method, process scale up, and formulation.

May 2024
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 58 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Ness Ziona, Israel
$17.5M
raised

DOT Compliance delivers the industry's first ready to use cloud-based quality and compliance management solution for regulated industries.

Apr 2024
Series B

Founder Contacts

19,000+ verified contacts

San Diego, United States
$132.0M
raised

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Apr 2024
Series B

Founder Contacts

19,000+ verified contacts

Seattle, United States
$4.7M
raised

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

Feb 2024
Series B

Founder Contacts

19,000+ verified contacts

Boston, United States
$50.0M
raised

Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.

Jan 2024
Series B

Founder Contacts

19,000+ verified contacts

Concord, United States
$75.0M
raised

Our purpose is to make every pregnancy around the world safer.

Jan 2024
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 58 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Manchester, United Kingdom
$23.2M
raised

Holiferm develops holistically improved fermentation technology for massive economic improvements.

Dec 2023
Series B

Founder Contacts

19,000+ verified contacts

Philadelphia, United States
$41.5M
raised

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

Nov 2023
Series B

Founder Contacts

19,000+ verified contacts

Risskov, Denmark
$81.4M
raised

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Nov 2023
Series B

Founder Contacts

19,000+ verified contacts

Pittsburgh, United States
$20.0M
raised

Free Market Health is a healthcare technology company empowering payers and pharmacies with a care-driven marketplace platform.

Nov 2023
Series B

Founder Contacts

19,000+ verified contacts

Clonmel, Ireland
$35.0M
raised

Shorla Pharma is an Irish specialty pharmaceutical company.

Oct 2023
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 58 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$72.0M
raised

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Sep 2023
Series B

Founder Contacts

19,000+ verified contacts

Cambridge, United States
$6.0M
raised

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

Aug 2023
Series B

Founder Contacts

19,000+ verified contacts

London, United Kingdom
$60.0M
raised

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.

Jul 2023
Series B

Founder Contacts

19,000+ verified contacts

Cambridge, United States
$150.0M
raised

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Jun 2023
Series B

Founder Contacts

19,000+ verified contacts

Oxford, United Kingdom
$12.5M
raised

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

May 2023
Series B

Founder Contacts

19,000+ verified contacts

Showing 26 to 50 of 58 companies

Ready to Connect with Series B Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 58 series b pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

58 Recently Funded Pharmaceutical Series B Startups (June 2026) | VCBacked